We feel very honored to be recipient of the i-Lab 2020 award. Support given to our ambitious project by Ministère de l’Enseignement Supérieur et de la Recherche (France) and Bpifrance will help developing Apmonia Therapeutics‘ innovative technology for the treatment of orphan oncology diseases.
Overall News
A new drug candidate in the fight against cancer
Press release: SATT Nord and Apmonia Therapeutics have entered into agreements in which Apmonia Therapeutics has been granted an exclusive worldwide license for the development
September 25, 2019
